| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Luc P Brion | |
| Edward F Bell | |||
| Talkad S Raghuveer | |||
| P2860 | cites work | Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation | Q30473664 |
| Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants? | Q30477134 | ||
| Vasculopathic hepatotoxicity associated with E-Ferol syndrome in low-birth-weight infants | Q33458532 | ||
| The precarious antioxidant defenses of the preterm infant | Q34065975 | ||
| History of vitamin E in infant nutrition | Q34173106 | ||
| Vitamins C and E: missing links in preventing preterm premature rupture of membranes? | Q34325254 | ||
| The European perspective on vitamin E: current knowledge and future research | Q34905197 | ||
| Postnatal changes in maternal and neonatal plasma antioxidant vitamins and the influence of smoking | Q35291569 | ||
| Vitamin E: maternal concentrations are associated with fetal growth | Q35809269 | ||
| Vitamin E therapy in retinopathy of prematurity | Q36293170 | ||
| Onset of retinopathy of prematurity as related to postnatal and postconceptional age | Q37297072 | ||
| Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial | Q38626864 | ||
| Upper limit of vitamin E in infant formulas | Q38758626 | ||
| Vitamin E and haemolytic anaemia in premature infants | Q39520656 | ||
| Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clini | Q39607013 | ||
| Current perspectives on vitamin E in infant nutrition | Q39661079 | ||
| The role of vitamin E in the nutrition of premature infants | Q40259955 | ||
| Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report | Q40925738 | ||
| Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment | Q41378544 | ||
| Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. | Q41668810 | ||
| Bioavailability of intramuscular vitamin E acetate in rabbits | Q41765704 | ||
| Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity | Q41886821 | ||
| Vitamin concentrations in very low birth weight infants given vitamins intravenously in a lipid emulsion: measurement of vitamins A, D, and E and riboflavin | Q42209232 | ||
| Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron | Q42237431 | ||
| Proceedings: Tocopherol and anaemia of prematurity | Q42722124 | ||
| Vitamin E supplementation reduces frequency of periventricular haemorrhage in very preterm babies | Q43885014 | ||
| Vitamin E response in infants fed a low-fat formula | Q44917361 | ||
| Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. | Q45283096 | ||
| Vitamin E supplementation in very-low-birth-weight infants: long-term follow-up at two different levels of vitamin E supplementation | Q47174873 | ||
| Serum vitamin E levels in very low-birth weight infants receiving vitamin E in parenteral nutrition solutions | Q47216074 | ||
| The vitamin status of low birth weight infants and their mothers | Q47233837 | ||
| Intestinal absorption of vitamin E in low birth weight infants | Q47239564 | ||
| Vitamin E and intraventricular hemorrhage in the newborn | Q49080132 | ||
| Use of a Lotus 1-2-3 spreadsheet to plot the confidence and the prediction intervals in linear regression analysis. | Q52501138 | ||
| Letter: Tocopherol and the anaemia of prematurity. | Q53998662 | ||
| Vitamin E for prematurity | Q66704939 | ||
| Role of Dietary Iron and Fat on Vitamin E Deficiency Anemia of Infancy | Q66914189 | ||
| Prevention of bronchopulmonary dysplasia with vitamin E administration during the acute stages of respiratory distress syndrome | Q66944246 | ||
| Biopharmaceutic Factors in Parenteral Administration of Vitamin E | Q66945994 | ||
| The use of intramuscular vitamin E in the premature infant. Optimum dose and iron interaction | Q67010385 | ||
| Vitamin E requirements of preterm infants | Q67363349 | ||
| Vitamin E supplementation and periventricular hemorrhage in the newborn | Q68178115 | ||
| Carboxyhemoglobin concentration as an index of bilirubin production in neonates with birth weights less than 1,500 grams: a randomized double-blind comparison of supplemental oral vitamin E and placebo | Q68213007 | ||
| Is routine vitamin E administration justified in very low-birthweight infants? | Q68518013 | ||
| Incidence, severity and time course of ROP in a randomized clinical trial of vitamin E prophylaxis | Q68550264 | ||
| Vitamin E-dependent anemia in the premature infant | Q68926323 | ||
| The early anaemia of the premature infant: is there a place for vitamin E supplementation? | Q69440939 | ||
| Influence of breast-feeding on the restoration of the low serum concentration of vitamin E and beta-carotene in the newborn infant | Q69504286 | ||
| Prophylaxis of periventricular hemorrhage in preterm babies by vitamin E supplementation | Q69572383 | ||
| Vitamin E and retinopathy of prematurity. Follow-up at one year | Q69910369 | ||
| Effect of vitamin E administration on alpha-tocopherol concentrations in the retina, choroid, and vitreous body of human neonates | Q70005478 | ||
| Vitamin E status in preterm infants fed human milk or infant formula | Q70075233 | ||
| Bilirubin production after supplemental oral vitamin E therapy in preterm infants | Q70075320 | ||
| Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants | Q70191592 | ||
| Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome | Q70227437 | ||
| The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia | Q70240432 | ||
| Vitamin E and retrolental fibroplasia. Improved visual outcome with early vitamin E | Q70271765 | ||
| The potential toxicity to neonates of multivitamin preparations used in parenteral nutrition | Q70342102 | ||
| Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ultrastructural mechanism of clinical efficacy | Q70409961 | ||
| Prevention and management of retrolental fibroplasia | Q70466832 | ||
| Vitamin E-dependent anemia in the premature infant. II. Relationships between gestational age and absorption of vitamin E | Q70533451 | ||
| Deficiency of neutrophil phagocytosis in premature infants: effect of vitamin E supplementation | Q71056478 | ||
| Vitamin E and vitamin E-quinone levels in red blood cells and plasma of newborn infants and their mothers | Q71082113 | ||
| The effect of vitamin E on erythrocyte hemolysis and lipid peroxidation in newborn premature infants | Q71204188 | ||
| Concentrations and total daily output of micronutrients in breast milk of mothers delivering preterm: a longitudinal study | Q71238815 | ||
| Effect of vitamin E on the development of oxygen-induced lung injury in neonates | Q71460164 | ||
| Vitamin E supplementation and the retinopathy of prematurity | Q71460168 | ||
| Selenium and vitamin E sufficiency in premature infants requiring total parenteral nutrition | Q71645728 | ||
| Retrolental fibroplasia and vitamin E | Q71862168 | ||
| Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation. A possible association with maternal lipoprotein (a) plasma levels | Q71949189 | ||
| Hemolytic Anemia in Vitamin E Deficiency | Q72021975 | ||
| Vitamin E and retrolental fibroplasia: ultrastructural support of clinical efficacy | Q72057194 | ||
| Vitamin E and Linoleic Acid in the Feeding of Premature Infants | Q72142107 | ||
| Tocopherol in Infants Fed Diets Rich in Polyunsaturated Fatty Acids | Q72142111 | ||
| Edema and hemolytic anemia in premature infants. A vitamin E deficiency syndrome | Q72145998 | ||
| Vitamin E deficiency: A previously unrecognized cause of hemolytic anemia in the premature infant | Q72332072 | ||
| Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial | Q72526370 | ||
| Vitamin E toxicity in neonatal piglets | Q72647635 | ||
| Syndrome in Premature Infants Associated with Low Plasma Vitamin E Levels and High Polyunsaturated Fatty Acid Diet | Q72794040 | ||
| Infants discriminate between natural and synthetic vitamin E | Q73188087 | ||
| Vitamin E status of infants at birth | Q73372986 | ||
| Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials | Q74034570 | ||
| Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status | Q74180092 | ||
| Plasma and erythrocyte alpha-tocopherol and plasma retinol concentrations in term infants fed formula enriched with long-chain polyunsaturated fatty acids | Q77658747 | ||
| P921 | main subject | vitamin | Q34956 |
| child mortality | Q61559 | ||
| prevention | Q1717246 | ||
| preterm infant | Q45051448 | ||
| P577 | publication date | 2003-10-20 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Vitamin E supplementation for prevention of morbidity and mortality in preterm infants |
| Q47173230 | A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants: A Randomized Clinical Trial |
| Q39052915 | Advances in understanding and management of retinopathy of prematurity |
| Q38169110 | Antioxidants and vision health: facts and fiction |
| Q96641336 | Appropriate and inappropriate vitamin supplementation in children |
| Q87387943 | Association between maternal vitamin E status and alpha-tocopherol levels in the newborn and colostrum |
| Q36633476 | Bench-to-bedside review: Neonatal sepsis-redox processes in pathogenesis |
| Q84767508 | Breast milk tocopherol content during the first six months in exclusively breastfeeding Greek women |
| Q30433993 | Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants |
| Q33655523 | Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses |
| Q92842083 | Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia |
| Q34371022 | Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease |
| Q24234228 | Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease |
| Q30867499 | Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. |
| Q33587865 | Dosage and formulation issues: oral vitamin E therapy in children |
| Q46720335 | Formation of reactive oxygen species in lung alveolar cells: effect of vitamin E deficiency |
| Q35786150 | Future applications of antioxidants in premature infants |
| Q36819324 | Hydrogen peroxide and central redox theory for aerobic life: A tribute to Helmut Sies: Scout, trailblazer, and redox pioneer |
| Q36355485 | Hypoxia-induced oxidative stress in ischemic retinopathy |
| Q92035862 | INTRAUTERINE GROWTH AND THE VITAMIN E STATUS OF FULL-TERM AND PRETERM NEWBORNS |
| Q27333775 | Impact of Dietary Tomato Juice on Changes in Pulmonary Oxidative Stress, Inflammation and Structure Induced by Neonatal Hyperoxia in Mice (Mus musculus) |
| Q34493004 | Increased vitamin E intake is associated with higher alpha-tocopherol concentration in the maternal circulation but higher alpha-carboxyethyl hydroxychroman concentration in the fetal circulation. |
| Q55399636 | Indications and complications of inpatient parenteral nutrition prescribed to children in a large tertiary referral hospital. |
| Q24234189 | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease |
| Q31040318 | Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. |
| Q38085782 | Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives? |
| Q48095108 | Ischemic Retinopathies: Oxidative Stress and Inflammation. |
| Q34610586 | Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation |
| Q24185832 | Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants |
| Q35989387 | Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. |
| Q92192919 | Mass Spectrometry in Advancement of Redox Precision Medicine |
| Q35734647 | Maternal intake of vitamin E and birth defects, national birth defects prevention study, 1997 to 2005. |
| Q88878915 | MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134) |
| Q64236665 | Monitoring of long-term parenteral nutrition in children with intestinal failure |
| Q38170063 | Neonatal intracerebral hemorrhage: mechanisms, managements, and the outcomes |
| Q37452432 | Neuroprotection in the newborn infant |
| Q33772042 | Neuroprotective therapies after perinatal hypoxic-ischemic brain injury |
| Q89761262 | Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle |
| Q90322182 | Nutrition and Lung Growth |
| Q37258163 | Nutrition, insulin-like growth factor-1 and retinopathy of prematurity |
| Q55069307 | Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop. |
| Q60047016 | Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation |
| Q36538140 | Parenteral nutrition additive shortages: the short-term, long-term and potential epigenetic implications in premature and hospitalized infants |
| Q37585988 | Pathogenesis and prevention of intraventricular hemorrhage |
| Q26772889 | Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity |
| Q64070205 | Prevention, Reduction and Repair of Brain Injury of the Preterm Infant |
| Q89667013 | Recent advances in perinatal neuroprotection |
| Q92865063 | Redox Systems Biology of Nutrition and Oxidative Stress |
| Q82071699 | Retinopathy of prematurity |
| Q46329882 | SMG-1 kinase attenuates mitochondrial ROS production but not cell respiration deficits during hyperoxia |
| Q58802979 | Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets |
| Q37337432 | Serum tocopherol levels in very preterm infants after a single dose of vitamin E at birth |
| Q27011376 | Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012 |
| Q54999086 | The progress of prophylactic treatment in retinopathy of prematurity. |
| Q37304229 | The relationship between macro- and micro-nutrients intake and risk of preterm premature rupture of membranes in pregnant women of Isfahan |
| Q37641067 | The use of older studies in meta-analyses of medical interventions: a survey. |
| Q45577125 | Timing of developmental reduction in epithelial glutathione redox potential is associated with increased epithelial proliferation in the immature murine intestine |
| Q64899259 | Turkish Neonatal and Turkish Ophthalmology Societies consensus guideline on the retinopathy of prematurity. |
| Q52669201 | Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia. |
| Q38248001 | Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury |
| Q47396232 | Vitamin A and E status in very low birth weight infants |
| Q34514153 | Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. |
| Q64960539 | Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. |
| Q35739407 | What is the appropriate intravenous dose of vitamin E for very-low-birth-weight infants? |
| Q95557443 | α-Tocopherol in breast milk of women with preterm delivery after a single postpartum oral dose of vitamin E |
Search more.